These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16304247)

  • 41. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline.
    Dean NC; Bateman KA; Donnelly SM; Silver MP; Snow GL; Hale D
    Chest; 2006 Sep; 130(3):794-9. PubMed ID: 16963677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An update for community-acquired bacterial pneumonia pharmacotherapy: what's new and where does it fit?
    DeBellis HF; Jones MC; Kincaid SE
    J Pharm Pract; 2012 Dec; 25(6):569-75. PubMed ID: 23065389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Azithromycin extended-release (Zmax) for sinusitis and pneumonia.
    Obstet Gynecol; 2006 Jan; 107(1):180-2. PubMed ID: 16394059
    [No Abstract]   [Full Text] [Related]  

  • 44. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
    Querol-Ribelles JM; Tenías JM; Querol-Borrás JM; Labrador T; Nieto A; González-Granda D; Martínez I
    Int J Antimicrob Agents; 2005 Jan; 25(1):75-83. PubMed ID: 15620830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levofloxacin in the treatment of community-acquired pneumonia.
    Noreddin AM; Elkhatib WF
    Expert Rev Anti Infect Ther; 2010 May; 8(5):505-14. PubMed ID: 20455679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of community-acquired pneumonia Down Under versus the United States: is it really that different?
    Mandell L
    Clin Infect Dis; 2008 May; 46(10):1522-4. PubMed ID: 18419485
    [No Abstract]   [Full Text] [Related]  

  • 47. Timing of correct parenteral antibiotic initiation and outcomes from severe bacterial community-acquired pneumonia in children.
    Muszynski JA; Knatz NL; Sargel CL; Fernandez SA; Marquardt DJ; Hall MW
    Pediatr Infect Dis J; 2011 Apr; 30(4):295-301. PubMed ID: 21030885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
    File TM; Milkovich G; Tennenberg AM; Xiang JX; Khashab MM; Zadeikis N
    Curr Med Res Opin; 2004 Sep; 20(9):1473-81. PubMed ID: 15383197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guidelines for treatment of community-acquired pneumonia.
    Kim MK; Nightingale C; Quintiliani R
    Conn Med; 2001 Aug; 65(8):473-5. PubMed ID: 11550446
    [No Abstract]   [Full Text] [Related]  

  • 50. Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia.
    Bohte R; Mattie H; van den Broek PJ
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2801-2. PubMed ID: 8593024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pharmacoeconomic evaluation of nosocomial pneumonia treatment].
    Krysanova IS; Kulikov AIu
    Antibiot Khimioter; 2008; 53(1-2):33-8. PubMed ID: 18942391
    [No Abstract]   [Full Text] [Related]  

  • 52. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
    Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children.
    Smith MJ; Kong M; Cambon A; Woods CR
    Pediatrics; 2012 May; 129(5):e1326-33. PubMed ID: 22492769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.
    Tribble DR; Sanders JW; Pang LW; Mason C; Pitarangsi C; Baqar S; Armstrong A; Hshieh P; Fox A; Maley EA; Lebron C; Faix DJ; Lawler JV; Nayak G; Lewis M; Bodhidatta L; Scott DA
    Clin Infect Dis; 2007 Feb; 44(3):338-46. PubMed ID: 17205438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of pneumonia caused by Legionella with azithromycin].
    Sánchez F; Mensa J; Martínez JA; Badia R; Albarracín M; Losa JE; Ruiz M; Marcos MA; Torres A; Soriano E
    Rev Esp Quimioter; 1998 Jun; 11(2):147-51. PubMed ID: 9795300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Azithromycin and bronchopulmonary infections].
    Leophonte P
    Pathol Biol (Paris); 1995 Jun; 43(6):534-41. PubMed ID: 8539078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The use of stepwise antibacterial therapy of community-acquired pneumonia].
    Iashchenko AV; Sinopal'nikov AI
    Klin Med (Mosk); 2014; 92(6):53-6. PubMed ID: 25799831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early discharge of infected patients through appropriate antibiotic use: a response.
    Ravakhah K; Kumar PD
    Arch Intern Med; 2001 Sep; 161(16):2047-8. PubMed ID: 11525712
    [No Abstract]   [Full Text] [Related]  

  • 59. Community acquired pneumonia and treatment priorities.
    Jagminas L
    Med Health R I; 2000 Dec; 83(12):396-8. PubMed ID: 11190130
    [No Abstract]   [Full Text] [Related]  

  • 60. Decisions about treating community-acquired pneumonia.
    Mandell L
    Ann Intern Med; 2005 Feb; 142(3):215-6. PubMed ID: 15684211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.